These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 10470198
1. Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL-6)? Wechsel HW, Feil G, Lahme S, Zumbragel A, Petri E, Bichler KH. Anticancer Res; 1999; 19(4A):2577-81. PubMed ID: 10470198 [Abstract] [Full Text] [Related]
7. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy. Casamassima A, Picciariello M, Quaranta M, Berardino R, Ranieri C, Paradiso A, Lorusso V, Guida M. J Urol; 2005 Jan; 173(1):52-5. PubMed ID: 15592024 [Abstract] [Full Text] [Related]
18. Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma. Wittke F, Hoffmann R, Buer J, Dallmann I, Oevermann K, Sel S, Wandert T, Ganser A, Atzpodien J. Br J Cancer; 1999 Mar 15; 79(7-8):1182-4. PubMed ID: 10098756 [Abstract] [Full Text] [Related]
19. Serum amyloid A: a biomarker for renal cancer. Fischer K, Theil G, Hoda R, Fornara P. Anticancer Res; 2012 May 15; 32(5):1801-4. PubMed ID: 22593464 [Abstract] [Full Text] [Related]
20. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R. Clin Cancer Res; 2006 Dec 01; 12(23):6989-97. PubMed ID: 17145819 [Abstract] [Full Text] [Related] Page: [Next] [New Search]